Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.480
-0.140 (-8.64%)
At close: Feb 5, 2026, 4:00 PM EST
1.460
-0.020 (-1.35%)
After-hours: Feb 5, 2026, 5:22 PM EST
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $138.33 million as of February 5, 2026. Its market cap has increased by 0.50% in one year.
Market Cap
138.33M
Enterprise Value
4.58M
1-Year Change
0.50%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $138.33M, a decrease of -84.43%. That is a compound annual growth rate of -33.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 151.42M | 1.89% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Black Diamond Therapeutics | 144.72M |
| Fate Therapeutics | 141.88M |
| Elicio Therapeutics | 141.55M |
| Cibus | 140.52M |
| Connect Biopharma Holdings | 139.20M |
| Unicycive Therapeutics | 138.62M |
| Adagene | 138.57M |
| Seres Therapeutics | 137.05M |